Literature DB >> 1379394

Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.

D Bresters1, H T Cuypers, H W Reesink, W P Schaasberg, C L van der Poel, E P Mauser-Bunschoten, M Houghton, Q L Choo, G Kuo, R Lesniewski.   

Abstract

A second generation ELISA for combined detection of antibodies to three hepatitis C virus (HCV) recombinant proteins, i.e. C100, C33c and core, was compared with a first generation anti-HCV ELISA in which only antibodies to C100 are detected. The results of the ELISAs were evaluated in 225 haemophilia patients (panel A) and 44 patients with non-A, non-B (NANB) hepatitis (panel B). HCV infection was established by cDNA-polymerase chain reaction (PCR) (in panel B only) and by studying the anti-HCV reaction patterns in 4 separate ELISAs for detection of antibodies to the recombinant proteins C100, C33c, core and a combination of two synthetic peptides sp67/65 derived from the C100 region. The sensitivity for the detection of HCV infection had increased from 0.92[95% confidence interval (CI): 0.87-0.95] to 1.00 (95% CI: 0.89-1.00) in haemophiliacs and from 0.84 (95% CI: 0.66-0.95) to 1.00 (95% CI: 0.89-1.00) in NANB hepatitis patients when the second generation ELISA was used instead of the first generation ELISA. Concurrently the chance of a false negative result was reduced in panel A and B from 0.37 to 0 and from 0.28 to 0, respectively. Analysis of anti-HCV reaction patterns revealed that 172 of 206 (83.5%) anti-HCV ELISA-reactive haemophilia patients had antibodies to all 4 antigens tested. In the NANB hepatitis patients 18 of 31 (58.1%) anti-HCV ELISA-reactive subjects reacted with 4 antigens. In the PCR tested panel of NANB hepatitis patients 2 subjects who showed antibody reactivity to only one antigen and 5 patients with reactivity to 2 antigens were PCR-positive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379394     DOI: 10.1111/j.1423-0410.1992.tb01201.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  12 in total

1.  Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.

Authors:  C Colin; P Vergnon; A M Jullien; S Excoffier; Y Matillon; C Trepo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

2.  Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides.

Authors:  D Rivanera; G Lorino; D Lilli; G Dicuonzo; C Mancini
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

Review 3.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Evaluation of a membrane filter assay system, Ortho HCV Ab Quick Pack, for detection of anti-hepatitis C virus antibody.

Authors:  T Kodama; S Ichiyama; K Sato; T Nada; N Nakashima
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Viral infections in newborns through exchange transfusion.

Authors:  R S Patil; P Wadgaonkar; S H Joshi; R H Merchant; S C Gupte
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

6.  Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.

Authors:  J T Stapleton; D Klinzman; W N Schmidt; M A Pfaller; P Wu; D R LaBrecque; J q Han; M J Phillips; R Woolson; B Alden
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.

Authors:  H Tanaka; T Hiyama; H Tsukuma; Y Okubo; H Yamano; A Kitada; I Fujimoto
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

Review 8.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany.

Authors:  J Riggert; D W Schwartz; A Uy; G Simson; F Jelinek; H Fabritz; W R Mayr; M Köhler
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.